ARCHIVES

Biotherapeutics Reports LAK/IL-2 Toxicity Reduced With Constant Infusion Of IL-2

This article is from The Cancer Letter archive.

Vol. 13 No. 16 | April 17, 1987

Download PDF Visit The Full Archive

Related Articles

Rituximab Maintenance Improves Survival In Relapse

February 27, 2009

Neulasta Reduces Incidence Of Febrile Neutropenia

February 22, 2013

NCI Releases List of Cancer Center Core Grant Funding for FY 2005; Univ. of New Mexico is the Newest NCI-Designated Center.

March 3, 2006

Impeding Reagan Budget Cuts Feared By Cancer Program Advocates; DeVita Asks Parity With NIH

February 13, 1981

In Brief: Panel Meeting Canceled; New Senior Executive Service Draws Enthusiastic Response At NCI

July 13, 1979

Clinton Declares Month of April Cancer Control Month

April 11, 1997